Austria OKs ion beam facility

After a long gestation, cancer research center gets regulatory approval

Written byNed Stafford
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Austrian government has given conditional approval for building a proton and carbon ion radiation research and treatment center in the small city of Wiener Neustadt, about 50 kilometers south of Vienna.

Erich Griesmayer, technical manager of the project, described Monday's (October 13) conditional approval by the Austrian Structure Commission as a "major victory" in the history of the cancer research and treatment project, which was first proposed in 1994 and has been dubbed MedAustron.

Griesmayer told The Scientist: "We now have the green light from the Austrian government, and this is very important."

The Austrian Structure Commission on Monday approved construction of MedAustron in Wiener Neustadt on condition that sound financing is secured and that the nation's sanitary council approves.

Griesmayer said he sees no barriers to sanitary council approval and believes the €117 million needed to build and equip the massive center can be secured sometime during next ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery